Triclofos

Triclofos
Clinical data
AHFS/Drugs.com International Drug Names
ATC code N05CM07 (WHO)
Identifiers
CAS Number 306-52-5 N 8060-81-9
PubChem (CID) 5563
ChemSpider 5362 YesY
UNII J712EO9048 YesY
ChEMBL CHEMBL1201317 N
ECHA InfoCard 100.005.624
Chemical and physical data
Formula C2H4Cl3O4P
Molar mass 229.383 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Triclofos is a sedative drug used rarely for treating insomnia, usually as a second-line treatment after other drugs have failed. Triclofos may cause dependence and should not be withdrawn suddenly. This drug should only be used for the short term relief of severe insomnia and should not be mixed with alcohol or other depressant drugs. Patients should not drive or use machinery after taking triclofos.

Triclofos is a prodrug which is metabolised in the liver into the active drug trichloroethanol. This delayed action means that the half-life of triclofos is fairly long and it may cause drowsiness the next day. Trichloroethanol may cause liver damage and triclofos should not be used for extended periods.

Side effects

Side effects may include: headache, rash, dizziness, flatulence, confusion, nightmares, dependence, diarrhoea, constipation, nausea, vomiting, abdominal pain, and ataxia.

References



    This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.